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INTRODUCTION
Cancer is the leading cause of morbidity and mortality worldwide. According to the International Agency for Research on Cancer (IARC) in 2012, 14 million new cases and eight million deaths were reported, out of which 60% happened in Africa, Asia, Central and South America (1) . Among women, cervical cancer is the second most common and the third leading cause of death (2) . It is estimated at more than 270,000 the number of deaths from this cancer and over 85% of them are concentrated in developing countries (1) .
In Brazil, this neoplasia is the fourth most common type (3) . In 2012, 5,264 deaths from this cancer were registered, of these, 1,678 (31.87%) in the Northeast. In the state of Pernambuco, 277 deaths were registered, of which 57 (20.57%) were residents in the city of Recife (4) . For the year 2015, 15,000 new cases of cervical cancer were estimated in the country (3) .
Infection by oncogenic types of Human Papilloma Virus (HPV) is the leading cause of cancer in the cervix (5) (6) . Types 16 and 18 are responsible for 70% of invasive cervical cancers (7) . Although HPV infection is a necessary cause for the occurrence of this cancer, it is not enough for it to develop. Persistent infections with this virus cause more than 500,000 cases of invasive cervical cancer worldwide every year (8) .
Decreases in incidence and mortality rates observed in developed countries can be attributed to organized cytology screening programs (9) (10) . The Pap smear is the primary screening strategy for cervical cancer recommended by the Department of Health in Brazil (11) .
In spite of presenting a decrease in standardized mortality rates, this particular cancer still has a relevant role as a cause of death (12) . The mortality rate allows the analysis of the impact of prevention programs, access to health services, quality of diagnosis and treatment and women's adherence to screening programs. In Brazil, achieving lower mortality rates means to achieve effective tracking and increased survival.
OBJECTIVE
Describe the occurrence of death from cervical cancer in Recife (PE), in the northeast region of Brazil, from 2000 to 2012.
METHOD

Ethical aspects
The project was approved by the Research Ethics Committees (CEP) of Centro Universitário Maurício de Nassau. The study met national and international ethical guidelines for research involving human beings.
Study design, site and period
An ecological time-series study was conducted using data from the Mortality Information System (Sistema de Informações sobre Mortalidade, SIM) of the Brazilian Ministry of Health, state of Pernambuco, in the 2000-2012 period.
Population, inclusion and exclusion criteria
The study population consisted of all deaths caused by cervical cancer (ICD10, C53) among women living in Recife, state of Pernambuco, in the 2000-2012 period.
Based on the information obtained from SIM after being granted authorization to access the data, variables including age, race/color, marital status, and occupation were analyzed. The variable "level of education" was not analyzed because 55.1% of the records were blank or had been filled out as "not known".
Study protocol
The data used were provided by the Secretariat of Health of Recife, after the signing of a consent term by the general manager of Health Surveillance.
Analysis of the results and statistics
For data analysis, descriptive statistics, including the distribution of frequency (absolute and relative) and measures of central tendency, were performed using the programs EpiInfo version 7 and Statistical Package for the Social Sciences (SPSS) version 15 for Windows, in which the mortality rates were calculated (number of deaths by cervical cancer/female population x 100,000).
RESULTS
During the study period, there were 695 deaths from cervical cancer. The mortality rate declined from 7.62 in 2000 to 6.81/100,000 women in 2012, representing a decrease of 10.62%, and an average annual reduction of 0.89% (Table 1) . Decline of mortality from cervical cancer Nascimento SG, Carvalho CPAL, Silva RS, Oliveira CM, Bonfim CV.
The minimum age was 19 years old and the maximum was 98 years old, with a total range of 79 years old and an average age of 56.8 years. Approximately 60% of deaths happened in women under 60 years old, highlighting the range of 50-59 years old (21.87%). There was a statistically significant difference (p <0.05) between the age groups ( Table 2) .
The nonparametric Chi-square test was performed to compare whether observed frequencies (number of deaths) were different from expected frequencies for the socio-demographic variable "Age Group". The value calculated for statistical test χ 2 with 7 degrees of freedom was 661.5. For any level of significance, the value tabulated is lower than the one calculated, i.e., the null hypothesis stating that observed frequencies are not different from expected frequencies is rejected. Therefore, there is a difference between frequencies and so, there is an association between the variables 'Age Group' and 'Ethnicity/Color'. There was a predominance of mixed race/color (53.24%), single (44.32%) and housewives (63.16%) ( Table 2) . Table 3 shows that most age groups showed a decrease in mortality rates, except for the age groups 30-39 and 80 and over, which increased by 0.76 and 5.34 respectively, the latter being strongly affected. In the age group up to 19 years old, one death was detected in 2009, whose coefficient was 1.50/100,000 women.
DISCUSSION
The results of this study show that mortality rates from cervical cancer had a steady decline, with a stable trend. During the period of 2006-2012, 830,565 cervicovaginal cytology tests in the public health system of Recife (PE) were performed, the year 2007 had the highest number of examinations (136,569), and this was the year with the lowest mortality rate (5.5 per 100,000) (13) .
Despite the decrease, the average rate found in the study was higher than that of Brazil (4) . There is a consensus in the literature that population screening for cervical cancer is the most important public health strategy because it reduces the incidence and, subsequently, mortality by identifying pre-invasive and invasive lesions in early stages, enabling a more effective treatment (14) (15) .
Over the past years, screening programs using cervical cytology (Pap smear) have greatly reduced cancer rates in the cervix (9) . In Canada, a survey described the relationship among incidence, mortality, and tracking, and showed a decrease in the indicators and that it was probably related to the advancement of cancer detection, which allows early treatment (16) . A study conducted in Serbia, created a risk index for predicting an abnormal result in Pap smear using the information on the age of first sexual intercourse, multiple partners, STD history and multiparity, to identify women at high risk of cervical cancer who should be submitted to further examination (17) .
However, the performance of Pap smear shows great variability among studies (18) . The significantly higher sensitivity of HPV testing raises the need for innovation in prevention strategies, with a recommendation for the inclusion of this test (18) (19) . The presence of the DNA of HPV in the cervix is detected by two efficient methods, i.e., Hybrid Capture II test and polymerase chain reaction (PCR), these tests are used to identify the presence of hazardous HPV viral infections that are associated with the origin of cancer (5) .
In Brazil, there is no availability of these tests in the routine of the Brazilian Unified Health System (SUS) due to their cost. Considering the comparison of cervical cytology and its cost with the HPV test, the latter can be used as an auxiliary method in cases with ambiguous diagnosis (20) . A study conducted in India proposes a two-step screening model: combining a low-cost highly sensitive test as Acetic acid (VIA) for the primary screening, followed by a more specific DNA of HPV test, as a positive screening. This can be a low-cost cervical screening strategy for countries with limited resources (21) .
The HPV vaccine has become a tool used by many countries to prevent cervical cancer and HPV (22) . The inclusion of the HPV vaccine in the Brazilian National Immunization Program by the Department of Health was a breakthrough, becoming one of the instruments to control this cancer in Brazil, especially among young women (23) .
French scholars, when researching the efficiency of the vaccine against HPV as a prophylactic measure, found that increasing vaccination coverage in the female population, or vaccinating girls before the age of 14, revealed to have a great impact on the incidence of this cancer (7) .
Results showed the majority of deaths occurred among women of mixed race/color, single and housewives. Possibly, socioeconomic factors contribute to a higher occurrence of the disease in this population; these findings come in line with previous studies (11, (24) (25) .
More and more women have been and should be seen as protagonists in prevention actions, while flexible schedules at health facilities allow for their conduction, so as to reduce inequalities in access, thus bringing more participation, regardless of their labor and occupational status (26) .
In this study, the age group above 80 years old had the highest mortality rates. In elderly women, the end of the fertile period seems to result in the reduction of gynecological consultations, leading to a break of prevention habits at a time in life in which the severity and incidence of neoplasms are higher (27) . The Brazilian Department of Health recommends the first examination at the age of 25 in women who already started sexual activity and should be done until they reach 64 years old and, thereafter, be discontinued when they have two negative tests in the course of five years (24) .
National and international research shows a decrease in mortality rates following the implementation of the screening program, nevertheless the positive effects of the program were not seen in elderly women (28) (29) .
Study limitations
Limitations of this study are incomplete records, leading to loss of information regarding the epidemiological aspects of cervical cancer deaths.
Contributions to the fields of nursing, health or public policy This research is of relevance to public health, since it can subsidize government agencies in the planning and development of programs and public policies aimed at reducing mortality, since cancer in the cervix is considered a cause of preventable death when diagnosed early.
CONCLUSION
Cervical cancer mortality proves to be a key indicator of the living conditions of the population and the standard of care to women's health. Despite the declining tendency of mortality from cervical cancer in Recife, the risk of death is still high, remaining as an important public health problem. The development of educational activities and the introduction of HPV testing as a primary screening tool are recommended to ensure the reduction of incidence and mortality from cervical cancer.
